Company intelligence / Profile preview

Verasonics

Kirkland, Washington, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Verasonics platforms have enabled thousands of studies and innovations in biomedical ultrasound research, including focused ultrasound therapies, neuromodulation, drug delivery, and advanced diagnostic imaging. Their Vantage and Vantage NXT systems are foundational tools worldwide across preclinical to translational research, but are not themselves clinical therapeutic programs or drugs.[1][2][3][5][6]

Therapeutic areas: CardiovascularImmunologyGastroenterologyNeurologyOtherOncology
Modalities: Device
Industry: Medical Imaging

Partnerships

Sonic ConceptsImFusion GmbHPhotoSound Technologies, Inc.

Beyond the preview

Go deeper on Verasonics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verasonics.

Explore the full profile